Severe Scalp Hair Loss in a Female Patient with Acromegaly Treated with Lanreotide Autogel After Unsuccessful Surgery

    October 2015 in “ Clinical Case Reports ”
    Cristina Álvarez-Escolá, Jersy Cárdenas-Salas, Beatriz Pelegrina … Beatriz Lecumberri
    Studysummary This study highlights that scalp hair loss is an underreported side effect of somatostatin analogs therapy, potentially linked to decreased GH/IGF-1 levels or a direct drug effect.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Exogenous IGF-1 Promotes Hair Growth by Stimulating Cell Proliferation and Downregulating TGF-β1 in C57BL/6 Mice In Vivo Growth Hormone & IGF Research · 2014
    2. Scalp Hair Loss After Transsphenoidal Adenomectomy in Patients With Acromegaly Clinical Endocrinology · 2012

    Related research 2

    1. Severe Scalp Hair Loss in a Female Patient with Acromegaly Treated with Lanreotide Autogel After Unsuccessful Surgery Clinical Case Reports · 2015
    2. Scalp Hair Loss After Transsphenoidal Adenomectomy in Patients With Acromegaly Clinical Endocrinology · 2012